Sci Signal, 2018 · DOI: 10.1126/scisignal.aao4180 · Published: April 3, 2018
After spinal cord injury, the interruption of axonal tracts leads to disconnection of neurons and loss of function. This study showed that nociceptin/ ORL1 signaling limits neural repair. Treatment with an ORL1 antagonist in a clinically relevant time window enhanced neural repair and recovery of mice after SCI.
ORL1 is a potential therapeutic target for promoting neural repair after spinal cord injury.
ORL1 antagonists could be developed as drugs to enhance recovery from traumatic CNS injuries.
Combining ORL1 antagonism with Nogo receptor inhibition may lead to greater functional recovery after SCI.